Lupus Science and Medicine podcast   /     Is Anifrolumab an effective treatment for lupus nephritis?

Summary

Dr. Anna Wolska engages in a discussion with renowned experts, Dr. Catharina Lindholm and Dr. David Jayne, to explore findings from the phase II TULIP Lupus Nephritis trial. This in-depth conversation centers on results from a clinical trial where they evaluated the efficacy of intensified anifrolumab treatment in individuals with active lupus nephritis.   Read the article: http://dx.doi.org/10.1136/lupus-2023-000910

Subtitle
Dr. Anna Wolska engages in a discussion with renowned experts, Dr. Catharina Lindholm and Dr. David Jayne, to explore findings from the phase II TULIP Lupus Nephritis trial. This in-depth conversation centers on results from a clinical trial where th...
Duration
12:44
Publishing date
2023-12-04 08:46
Link
https://lupusbmj.podbean.com/e/is-anifrolumab-an-effective-treatment-for-lupus-nephritis/
Contributors
  BMJ Group
author  
Enclosures
https://mcdn.podbean.com/mf/web/gzrdmr/LS_M_Podcast_-_JayneLindholmbraca.mp3
audio/mpeg

Shownotes

Dr. Anna Wolska engages in a discussion with renowned experts, Dr. Catharina Lindholm and Dr. David Jayne, to explore findings from the phase II TULIP Lupus Nephritis trial. This in-depth conversation centers on results from a clinical trial where they evaluated the efficacy of intensified anifrolumab treatment in individuals with active lupus nephritis.

 

Read the article: http://dx.doi.org/10.1136/lupus-2023-000910